Metastable Crystallins: Structure and Stabilization

亚稳态晶体蛋白:结构和稳定性

基本信息

  • 批准号:
    9265858
  • 负责人:
  • 金额:
    $ 39.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-01 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many diverse diseases, including cataract, some types of glaucoma, Alzheimer disease, diabetes and cancer to name only a few, are now known to share the common feature of aggregated, misfolded or modified protein deposits. The pathological hallmark in this group of diseases is protein aggregation and deposition in specific cells, tissues or organs. The pathological similarities indicate that common principles that govern protein interactions underlie protein misfolding degenerative diseases. Cataract is a classic example of a protein misfolding and aggregation disease. Cataract, a major cause of blindness in the world, develops as a result of age-related modifications and aggregation of the lens proteins. α-crystallin accounts for nearly 40% of the adult lens proteins but its structure-function is yet to be fully understood. The chaperone-like activity of α-crystallin is believed to play a central role in maintaining lens transparency. During aging, lens crystallins undergo truncation and these modifications correlate with lens crystallin aggregations responsible for light scattering. It is well established that the addition of α-crystallin to aggregating proteins stops a further increase in aggregation and light scattering. We have demonstrated that specific sequences in α-crystallin subunits suppress aggregation of denaturing proteins. However, the full potential of α-crystallin-derived peptides (mini-chaperones) is yet to be realized. To enhance our understanding of the role of non-native interactions in cataract formation, we propose the following specific aims: Aim 1. Identify the sequences involved in abnormal interactions of αA-crystallin subunits that lead to protein aggregation in human cataract-causing A-crystallin mutants (αAR49C, αAF71V, αAG98R and αAR116H) using novel deuterated cross linkers, biotynylated reagents and peptide arrays. Aim 2. Determine the mechanism and efficacy of αA-crystallin-derived mini-chaperone in preventing the aggregation of metastable αA- crystallins (mutants and truncated crystallins) and restoring chaperone activity. The specific aims will be accomplished using novel cross-linkers and mass spectrometric methods. We will also use site-directed mutagenesis and cell culture expression and analysis systems to confirm the cross linking data. These innovative studies will give us new insights into potential interventions for protein misfolding diseases, not only of the eye but also of other parts of the body.
描述(由申请人提供):现在已知许多不同的疾病,包括白内障、某些类型的青光眼、阿尔茨海默病、糖尿病和癌症,仅举几例,都具有聚集、错误折叠或修饰的蛋白质沉积的共同特征。这组疾病的病理学标志是蛋白质聚集和沉积在特定细胞、组织或器官中。病理学的相似性表明,共同的原则,管理蛋白质相互作用的蛋白质错误折叠退行性疾病的基础。白内障是蛋白质错误折叠和聚集疾病的典型例子。白内障是世界上致盲的主要原因,其发展是透镜蛋白质的年龄相关性改变和聚集的结果。α-晶状体蛋白约占成人透镜蛋白的40%,但其结构与功能尚不完全清楚。的分子伴侣样活性 α-晶状体蛋白被认为在维持透镜透明度中起核心作用。在老化过程中,透镜晶状体蛋白经历截短,并且这些修饰与负责光散射的透镜晶状体蛋白聚集相关。已经确定,向聚集蛋白中加入α-晶状体蛋白可以阻止聚集和光散射的进一步增加。我们已经证明α-晶状体蛋白亚基中的特定序列抑制变性蛋白的聚集。然而,α-stac衍生肽(迷你分子伴侣)的全部潜力尚未实现。加强 基于我们对白内障形成中非天然相互作用的理解,我们提出了以下具体目标:目标1。使用新型氘代交联剂、生物素化试剂和肽阵列鉴定导致人白内障A-晶状体蛋白突变体(α AR 49 C、α AF 71 V、α AG 98 R和α AR 116 H)中蛋白质聚集的α A-晶状体蛋白亚基异常相互作用所涉及的序列。目标2.确定α A-晶体蛋白衍生的微型分子伴侣在防止亚稳态αA-晶体蛋白(突变体和截短晶体蛋白)聚集和恢复分子伴侣活性方面的机制和有效性。具体目标将使用新型交联剂和质谱方法来实现。我们还将使用定点诱变和细胞培养表达和分析系统来确认交联数据。这些创新的研究将为我们提供新的见解,以了解蛋白质错误折叠疾病的潜在干预措施,不仅是眼睛,而且是身体的其他部位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISHNA K SHARMA其他文献

KRISHNA K SHARMA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISHNA K SHARMA', 18)}}的其他基金

Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    8470982
  • 财政年份:
    2013
  • 资助金额:
    $ 39.17万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    9132472
  • 财政年份:
    2013
  • 资助金额:
    $ 39.17万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    10200048
  • 财政年份:
    2013
  • 资助金额:
    $ 39.17万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    8841373
  • 财政年份:
    2013
  • 资助金额:
    $ 39.17万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    10657220
  • 财政年份:
    2013
  • 资助金额:
    $ 39.17万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    8657443
  • 财政年份:
    2013
  • 资助金额:
    $ 39.17万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    9769023
  • 财政年份:
    2013
  • 资助金额:
    $ 39.17万
  • 项目类别:
Crystallin-Derived Anti-Chaperones in the Lens
晶状体中的晶状体蛋白衍生的反伴侣分子
  • 批准号:
    8306862
  • 财政年份:
    2010
  • 资助金额:
    $ 39.17万
  • 项目类别:
Crystallin-Derived Mini-Chaperones as Protein Aggregation Inhibitors
晶状体蛋白衍生的微型伴侣作为蛋白质聚集抑制剂
  • 批准号:
    7976444
  • 财政年份:
    2010
  • 资助金额:
    $ 39.17万
  • 项目类别:
Crystallin-Derived Anti-Chaperones in the Lens
晶状体中的晶状体蛋白衍生的反伴侣分子
  • 批准号:
    7992774
  • 财政年份:
    2010
  • 资助金额:
    $ 39.17万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 39.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了